Elanco Animal Health (ELAN) Return on Capital Employed (2018 - 2026)

Elanco Animal Health has disclosed Return on Capital Employed across 9 years of filings, most recently posting 7.34% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 7.34%, up 1397.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.34% (up 1397.0% YoY), and the FY2025 annual result was 6.98%, up 1943.0% from the prior year.
• Return on Capital Employed came in at 7.34% for Q1 2026 at Elanco Animal Health, up from 6.7% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 7.34% in Q1 2026 to a low of 26.01% in Q2 2024.
• The 5-year median for Return on Capital Employed is 13.78% (2023), against an average of 11.98%.
• Across the five-year window, Return on Capital Employed sank 1255 bps in 2024 and soared 2589 bps in 2025, its largest moves.
• Elanco Animal Health's Return on Capital Employed stood at 14.68% in 2022, then tumbled by 62 bps to 23.84% in 2023, then jumped by 45 bps to 13.02% in 2024, then surged by 151 bps to 6.7% in 2025, then advanced by 9 bps to 7.34% in 2026.
• The last three Return on Capital Employed figures came in at 7.34% (Q1 2026), 6.7% (Q4 2025), and 0.7% (Q3 2025), per Business Quant data.